Abstract: Inhibitors of glucosylceramide degradation, to pharmaceutical compositions containing same and to the use of same in the treatment of diseases of the motor units, such as amyotrophic lateral sclerosis.
Type:
Grant
Filed:
September 29, 2020
Date of Patent:
September 10, 2024
Assignees:
SPEDDING RESEARCH SOLUTIONS, UNIVERSITE DE STRASBOURG, INSERM—INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Inventors:
Michael Spedding, Alexandre Henriques, Jean-Philippe Loeffler